Expensive cancer drugs could break the healthcare system.
The cancer drug Keytruda is helping some patients in Germany. However, it is too expensive for the healthcare system. This is causing problems for insurance companies.
Keytruda is a successful drug for treating cancer. German healthcare is struggling to pay for it. Pharmaceutical companies are making a lot of money from the drug. This is making the situation worse. There are worries about people not being able to get the treatment they need.
Summarized from the sources above. Read the originals for the full story.
Highlights
Keytruda Saves Lives
The drug Keytruda is a major breakthrough for cancer patients.
Keytruda Costs Too Much
Keytruda is too expensive for Germany’s healthcare system.
Insurance Companies Struggle
High costs are causing insurance companies to have problems.
Pharmaceutical Profits Rise
Pharmaceutical companies are increasing profits within Germany.
Access to Treatment Concerns
This raises worries about patients getting needed treatments.